← All trials
NCT03185624
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 12, 2017
- Primary completion
- Jan 31, 2018
- Completion date
- Jul 31, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 80
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Sun Yat-Sen UniversityLead sponsor
- Tsinghua UniversityCollaborator
- Zhejiang UniversityCollaborator
- Sun Yat-Sen UniversityCollaborator
- Huazhong University of Science and TechnologyCollaborator
- People's Liberation Army of ChinaCollaborator
- Jiao Tong UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.